Elite Pharmaceuticals Inc (ELTP)

[WeeZuhl]

Dang.


10K-2016:

Research and development costs were $12.4 million, $14.7 million and $4.0 million for the years ended March 31, 2016, 2015 and 2014, respectively, with such costs relating almost entirely to the development of SequestOx™, the first product developed by Elite that incorporates the technology.

Almost like real money. Where would we be today if we had our own approved NDA for SequestOx AND our line of generic opioids in tact AND the CNS stimulants? Besides a tidy bit more income, this would also be a more diverse portfolio. I guess it's like they say, we just can't have nice things around here.